201 related articles for article (PubMed ID: 29871649)
21. Orphan CpG islands define a novel class of highly active enhancers.
Bell JSK; Vertino PM
Epigenetics; 2017 Jun; 12(6):449-464. PubMed ID: 28448736
[TBL] [Abstract][Full Text] [Related]
22. Multi-network approach to identify differentially methylated gene communities in cancer.
R V; Nazeer KAA
Gene; 2019 May; 697():227-237. PubMed ID: 30797996
[TBL] [Abstract][Full Text] [Related]
23. Identification of activated enhancers and linked transcription factors in breast, prostate, and kidney tumors by tracing enhancer networks using epigenetic traits.
Rhie SK; Guo Y; Tak YG; Yao L; Shen H; Coetzee GA; Laird PW; Farnham PJ
Epigenetics Chromatin; 2016; 9():50. PubMed ID: 27833659
[TBL] [Abstract][Full Text] [Related]
24. Whole-epigenome analysis in multiple myeloma reveals DNA hypermethylation of B cell-specific enhancers.
Agirre X; Castellano G; Pascual M; Heath S; Kulis M; Segura V; Bergmann A; Esteve A; Merkel A; Raineri E; Agueda L; Blanc J; Richardson D; Clarke L; Datta A; Russiñol N; Queirós AC; Beekman R; Rodríguez-Madoz JR; San José-Enériz E; Fang F; Gutiérrez NC; García-Verdugo JM; Robson MI; Schirmer EC; Guruceaga E; Martens JH; Gut M; Calasanz MJ; Flicek P; Siebert R; Campo E; Miguel JF; Melnick A; Stunnenberg HG; Gut IG; Prosper F; Martín-Subero JI
Genome Res; 2015 Apr; 25(4):478-87. PubMed ID: 25644835
[TBL] [Abstract][Full Text] [Related]
25. Reactivation of tumour suppressor in breast cancer by enhancer switching through NamiRNA network.
Liang Y; Lu Q; Li W; Zhang D; Zhang F; Zou Q; Chen L; Tong Y; Liu M; Wang S; Li W; Ren X; Xu P; Yang Z; Dong S; Zhang B; Huang Y; Li D; Wang H; Yu W
Nucleic Acids Res; 2021 Sep; 49(15):8556-8572. PubMed ID: 34329471
[TBL] [Abstract][Full Text] [Related]
26. Epigenetic targeting of the Nanog pathway and signaling networks during chemical carcinogenesis.
Tommasi S; Zheng A; Yoon JI; Besaratinia A
Carcinogenesis; 2014 Aug; 35(8):1726-36. PubMed ID: 24480805
[TBL] [Abstract][Full Text] [Related]
27. DBCAT: database of CpG islands and analytical tools for identifying comprehensive methylation profiles in cancer cells.
Kuo HC; Lin PY; Chung TC; Chao CM; Lai LC; Tsai MH; Chuang EY
J Comput Biol; 2011 Aug; 18(8):1013-7. PubMed ID: 21214365
[TBL] [Abstract][Full Text] [Related]
28. SOX30, a novel epigenetic silenced tumor suppressor, promotes tumor cell apoptosis by transcriptional activating p53 in lung cancer.
Han F; Liu W; Jiang X; Shi X; Yin L; Ao L; Cui Z; Li Y; Huang C; Cao J; Liu J
Oncogene; 2015 Aug; 34(33):4391-402. PubMed ID: 25435374
[TBL] [Abstract][Full Text] [Related]
29. Editing DNA Methylation in the Mammalian Genome.
Liu XS; Wu H; Ji X; Stelzer Y; Wu X; Czauderna S; Shu J; Dadon D; Young RA; Jaenisch R
Cell; 2016 Sep; 167(1):233-247.e17. PubMed ID: 27662091
[TBL] [Abstract][Full Text] [Related]
30. DNA methylation landscapes of 1538 breast cancers reveal a replication-linked clock, epigenomic instability and cis-regulation.
Batra RN; Lifshitz A; Vidakovic AT; Chin SF; Sati-Batra A; Sammut SJ; Provenzano E; Ali HR; Dariush A; Bruna A; Murphy L; Purushotham A; Ellis I; Green A; Garrett-Bakelman FE; Mason C; Melnick A; Aparicio SAJR; Rueda OM; Tanay A; Caldas C
Nat Commun; 2021 Sep; 12(1):5406. PubMed ID: 34518533
[TBL] [Abstract][Full Text] [Related]
31. MN1 overexpression is driven by loss of DNMT3B methylation activity in inv(16) pediatric AML.
Larmonie NSD; Arentsen-Peters TCJM; Obulkasim A; Valerio D; Sonneveld E; Danen-van Oorschot AA; de Haas V; Reinhardt D; Zimmermann M; Trka J; Baruchel A; Pieters R; van den Heuvel-Eibrink MM; Zwaan CM; Fornerod M
Oncogene; 2018 Jan; 37(1):107-115. PubMed ID: 28892045
[TBL] [Abstract][Full Text] [Related]
32. The clinical value of aberrant epigenetic changes of DNA damage repair genes in human cancer.
Gao D; Herman JG; Guo M
Oncotarget; 2016 Jun; 7(24):37331-37346. PubMed ID: 26967246
[TBL] [Abstract][Full Text] [Related]
33. Genome-wide characterization of aberrant DNA methylation patterns and the potential clinical implications in patients with endometrial cancer.
Wang Y; Liu D; Jin X; Song H; Lou G
Pathol Res Pract; 2019 Jan; 215(1):137-143. PubMed ID: 30449607
[TBL] [Abstract][Full Text] [Related]
34. Walking pathways with positive feedback loops reveal DNA methylation biomarkers of colorectal cancer.
Kel A; Boyarskikh U; Stegmaier P; Leskov LS; Sokolov AV; Yevshin I; Mandrik N; Stelmashenko D; Koschmann J; Kel-Margoulis O; Krull M; Martínez-Cardús A; Moran S; Esteller M; Kolpakov F; Filipenko M; Wingender E
BMC Bioinformatics; 2019 Apr; 20(Suppl 4):119. PubMed ID: 30999858
[TBL] [Abstract][Full Text] [Related]
35. Towards understanding the breast cancer epigenome: a comparison of genome-wide DNA methylation and gene expression data.
Singhal SK; Usmani N; Michiels S; Metzger-Filho O; Saini KS; Kovalchuk O; Parliament M
Oncotarget; 2016 Jan; 7(3):3002-17. PubMed ID: 26657508
[TBL] [Abstract][Full Text] [Related]
36. Mutual regulation of microRNAs and DNA methylation in human cancers.
Wang S; Wu W; Claret FX
Epigenetics; 2017 Mar; 12(3):187-197. PubMed ID: 28059592
[TBL] [Abstract][Full Text] [Related]
37. Using Illumina Infinium HumanMethylation 450K BeadChip to explore genome‑wide DNA methylation profiles in a human hepatocellular carcinoma cell line.
Sun N; Zhang J; Zhang C; Shi Y; Zhao B; Jiao A; Chen B
Mol Med Rep; 2018 Nov; 18(5):4446-4456. PubMed ID: 30221710
[TBL] [Abstract][Full Text] [Related]
38. Hypermethylation of
Bai R; Mei J; Hu W
DNA Cell Biol; 2020 Nov; 39(11):2052-2058. PubMed ID: 32907377
[TBL] [Abstract][Full Text] [Related]
39. Pan-Cancer Analysis Reveals Differential Susceptibility of Bidirectional Gene Promoters to DNA Methylation, Somatic Mutations, and Copy Number Alterations.
Thompson JA; Christensen BC; Marsit CJ
Int J Mol Sci; 2018 Aug; 19(8):. PubMed ID: 30081598
[TBL] [Abstract][Full Text] [Related]
40. Genomic insights into cancer-associated aberrant CpG island hypermethylation.
Sproul D; Meehan RR
Brief Funct Genomics; 2013 May; 12(3):174-90. PubMed ID: 23341493
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
